The firm plans to seek full commercial approval for its assay, which integrates biomarker identification with a patient's electronic medical record, later this year.
BGI will study pancreatic cancer with a group at Johns Hopkins and develop a diagnostic test for preterm birth detection with Mount Sinai Hospital researchers.
Coming one year after LabCorp's acquisition of Mount Sinai's Clinical Outreach business, the new partnership will standardize lab operations at seven hospitals.
The two parties are exploring opportunities to collaborate on research projects, including next-generation genomics and molecular diagnostic test development.
